Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04691502 + Letrozole in ER+/HER2- Breast Cancer
NCT01430585Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of PF-04691502 in breast cancer, sponsored by Pfizer. Started Mar 2012; status: terminated.
02
Drugs
PF-04691502
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01430585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430585.